⌘K
Loading ticker…
Neogen Corp · Healthcare · Pharmaceutical Products
As of 2026-06-26, Neogen Corp (NEOG) has a 3-month relative strength percentile of 50 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.7%, relative volume 2.45×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
50 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
NEOG is in a stage 2 uptrend, week 1. Currently in a 87-day base; basing ADR 4.3% (broad 4.6%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 5.3% / 17.0%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
NEOG is held by 8 ETFs as of Mar 2026. Top owner: IJR at 0.13% weight, $121M notional. Top 3 carry $235M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.13% | $121M |
| VTIVanguard Total Stock Market ETF | 0.00% | $64M |
| IWMiShares Russell 2000 ETF | 0.07% | $50M |
| VBVanguard Small Cap ETF | 0.03% | $47M |
| VBRVanguard Small Cap Value ETF | 0.05% | $30M |
| VXFVanguard Extended Market ETF | 0.03% | $23M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| XHEState Street SPDR S&P Health Care Equipment ETF | 1.64% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NEOG Jan avg: 14.56% median: 17.49% win: 50% σ: 34.11% n: 4 2022-04-12 → 2026-05-29 | NEOG Feb avg: -2.22% median: -1.21% win: 50% σ: 14.72% n: 4 2022-04-12 → 2026-05-29 | NEOG Mar avg: -8.63% median: -10.97% win: 25% σ: 9.63% n: 4 2022-04-12 → 2026-05-29 | NEOG Apr avg: -16.88% median: -14.95% win: 20% σ: 16.36% n: 5 2022-04-12 → 2026-05-29 | NEOG May avg: 3.98% median: 1.57% win: 80% σ: 7.84% n: 5 2022-04-12 → 2026-05-29 | NEOG Jun avg: 3.96% median: 4.95% win: 50% σ: 20.87% n: 4 2022-04-12 → 2026-05-29 (current) | NEOG Jul avg: 2.22% median: 1.95% win: 50% σ: 6.52% n: 4 2022-04-12 → 2026-05-29 | NEOG Aug avg: 3.75% median: 0.50% win: 50% σ: 14.12% n: 4 2022-04-12 → 2026-05-29 | NEOG Sep avg: -14.05% median: -11.18% win: 0% σ: 15.37% n: 4 2022-04-12 → 2026-05-29 | NEOG Oct avg: -8.05% median: -10.28% win: 25% σ: 12.25% n: 4 2022-04-12 → 2026-05-29 | NEOG Nov avg: 8.91% median: 6.63% win: 50% σ: 13.36% n: 4 2022-04-12 → 2026-05-29 | NEOG Dec avg: 3.24% median: 4.43% win: 50% σ: 16.90% n: 4 2022-04-12 → 2026-05-29 |